Search
for
Sort by
Research 61–90 of 1000+
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Evaluation of the Therapeutic Effect of Palash Basti in the Polyendocrine metabolic ovarian syndrome (PMOS): A Case Report
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Mapping Metabolism: Monitoring Lactate Dehydrogenase Activity Directly in Tissue
- Study on the mechanism of cadmium chloride pollution accelerating skin tissue metabolism disorder, aging and inhibiting hair regeneration
- Photo-downregulation of SIRT4 mitigates aging in mice by enhancing H3K9ac via fatty acid metabolism
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Correction of Diffuse Alopecia in Iron Deficiency Anemia
- Vitamin D metabolism and function in the skin
- Imbalance of some Trace Elements and their Correction in Alopecia Areata
- MESOTHERAPY AS A METHOD OF CORRECTION OF ALOPESIA IN PATIENTS AFTER BARIATRY
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Controlled Release of the α-Tocopherol-Derived Metabolite α-13′-Carboxychromanol from Bacterial Nanocellulose Wound Cover Improves Wound Healing
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- Dermatologic Manifestations in Patients with Metabolic Syndrome in Brazil
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Morphological changes in the skin in a rat model of stress-induced alopecia and their correction with nutrients
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes